Hypertension and cerebrovascular diseases: A specific role of vascular protection for the prevention of dementia

Journal of Cardiovascular Pharmacology

Volumn 38, Issue SUPPL. 2, 2002, Pages

  Semplicini, A ^a   Maresca, A ^a   Sartori, M ^a   Calo L ^a   Pessina, A C ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

Cerebral perfusion; Cerebrovascular diseases; Dementia; Hypertension; Single photon emission computer aided tomography

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; LACIDIPINE;

BLOOD BRAIN BARRIER; BRAIN ATROPHY; BRAIN INFARCTION; BRAIN PERFUSION; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; CONFERENCE PAPER; DEAFFERENTATION; DEMENTIA; DIABETES MELLITUS; HUMAN; HYPERTENSION; NEUROPROTECTION; PRIORITY JOURNAL; STROKE;

EID: 0036134967     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200111002-00019     Document Type: Conference Paper

References (10)

1. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context
2. Stroke incidence, prevalence, and survival. Secular trends in Rochester, Minnesota, through 1989
3. Neuropsychological impairment correlates with hypoperfusion and hypometabolism but not with severity of white matter lesions on MRI in patients with cerebral microangiopathy
4. Hypertensive disease and cerebral circulation
5. SPECT evaluation of cerebral perfusion in uncomplicated essential hypertension and effects of enalapril
6. Risk factors for silent cerebral infarcts in subcortical white matter and basal ganglia
7. Cerebral perfusion in hypertensive patients: Effects of lacidipine and hydrochlorothiazide
8. Hypertension is related to cognitive impairment: A 20 year follow-up of 999 men
9. Prevention of stroke by anti-hypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program (SHEP)
10. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial